CD14 and cancer: Several samples from four patients were analyzed (12 samples in total), and, in those samples with intracellular CXCL10 staining, the signal was detected in the CD14+ cells, but not in the CD15+ cells, confirming the role of myeloid cells in the BCG-mediated response against cancer secreting this chemokine (Figure 5).